Barclays Maintains an 'Overweight/Top Pick' on Bed Bath and Beyond (BBBY); Cost Plus (CPWM) Good Strategic Partner

Barclays maintains an 'Overweight' on Bed Bath and Beyond (NASDAQ: BBBY) price target of $76.00.

Analyst, Alan M. Rifkin, said, "BBBY remains a Top Pick. We believe Cost Plus (Nasdaq: CPWM) represents a good strategic partner as it offers unique product and categories that BBBY currently has limited or no exposure to. In our view, Cost Plus will also extend BBBY's customer reach. BBBY management expects the acquisition to close in 2Q with slight accretion likely in 2012."

For an analyst ratings summary and ratings history on Bed Bath and Beyond click here. For more ratings news on Bed Bath and Beyond click here.

Shares of Bed Bath and Beyond closed at $72.08 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• AssetMark Financial Holdings Inc. (AMK) Signs Definitive Agreement to be Acquired by GTCR
• Anglo American does not find BHP $39 billion offer attractive, sources say
• Hawaiian Electric Industries (HE) Said To Weigh Sale Of American Savings Bank - Bloomberg